Related Experiment Videos
Complement in inflammatory tissue damage and disease
Tom E Mollnes1, Wen-Chao Song, John D Lambris
1Institute of Immunology, The National Hospital, University of Oslo, Norway. t.e.mollnes@labmed.uio.no
Trends in Immunology
|April 4, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
New Analogs of the Compstatin Family of Clinical Complement Inhibitors with Low Picomolar Target Affinity.
Journal of medicinal chemistry·2026
Same author
Clinical C3 Inhibition With AMY-101 Reveals Novel Insights Into IL-8-Driven Inflammation in COVID-19.
Immunology·2025
Same author
Cp40-mediated complement C3 inhibition dampens inflammasome activation and inflammatory mediators storm induced by Bitis arietans venom.
International immunopharmacology·2025
Same author
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.
Cancer immunology research·2024
Same author
Monocyte uptake of polymeric peptidoglycan is bimodal and governed by complement C3 and C4 opsonins.
JCI insight·2024
Same journal
Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.
Trends in immunology·2026
Same journal
Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.
Trends in immunology·2026
Same journal
Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.
Trends in immunology·2026
Same journal
Metabolic regulatory nodes of the inflammasome and inflammatory cell death.
Trends in immunology·2026
Same journal
T cell control of the intestinal barrier and gut microbiota during ageing.
Trends in immunology·2026